Scynexis' Series D Round

Scynexis raised a round of funding on May 21, 2012.

Scynexis is a pharmaceutical company committed to the discovery, development and commercialization of novel anti-infectives to address significant unmet therapeutic needs. The company is developing it…

Articles about Scynexis' Series D Round: